Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation
Clinical trial NCT04463004 · COMPLETED
Trial details
- NCT number
- NCT04463004
- Sponsor
- Virginia Commonwealth University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-02
- Primary completion
- 2020-11-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.